Article
Variants of GCKR affect both β-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2.
Diabetes care - 1 May 2011
Bonetti Sara, Trombetta Maddalena, Boselli Maria Linda, Turrini Fabiola, Malerba Giovanni, Trabetti Elisabetta, Pignatti Pier Franco, Bonora Enzo, Bonadonna Riccardo C
Abstract excerpt
OBJECTIVE: In genome-wide association studies, performed mostly in nondiabetic individuals, genetic variability of glucokinase regulatory protein (GCKR) affects type 2 diabetes-related phenotypes, kidney function, and risk of chronic kidney disease (CKD). We tested whether GCKR variability affects type 2 diabetes or kidney-related phenotypes in newly diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: In 509...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
